bioAffinity Technologies Statistics
Total Valuation
BIAF has a market cap or net worth of $3.47 million. The enterprise value is $1.76 million.
| Market Cap | 3.47M |
| Enterprise Value | 1.76M |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026, before market open.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BIAF has 4.53 million shares outstanding. The number of shares has increased by 492.85% in one year.
| Current Share Class | 4.53M |
| Shares Outstanding | 4.53M |
| Shares Change (YoY) | +492.85% |
| Shares Change (QoQ) | +0.54% |
| Owned by Insiders (%) | 2.41% |
| Owned by Institutions (%) | 6.38% |
| Float | 4.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.61 |
| Forward PS | 0.60 |
| PB Ratio | 0.94 |
| P/TBV Ratio | 2.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.38.
| Current Ratio | 1.36 |
| Quick Ratio | 1.19 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -265.14 |
Financial Efficiency
Return on equity (ROE) is -622.65% and return on invested capital (ROIC) is -184.95%.
| Return on Equity (ROE) | -622.65% |
| Return on Assets (ROA) | -107.12% |
| Return on Invested Capital (ROIC) | -184.95% |
| Return on Capital Employed (ROCE) | -242.89% |
| Weighted Average Cost of Capital (WACC) | -0.62% |
| Revenue Per Employee | $99,296 |
| Profits Per Employee | -$278,596 |
| Employee Count | 57 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 64.93 |
Taxes
In the past 12 months, BIAF has paid $35,347 in taxes.
| Income Tax | 35,347 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.48% in the last 52 weeks. The beta is -1.11, so BIAF's price volatility has been lower than the market average.
| Beta (5Y) | -1.11 |
| 52-Week Price Change | -92.48% |
| 50-Day Moving Average | 1.48 |
| 200-Day Moving Average | 1.91 |
| Relative Strength Index (RSI) | 26.79 |
| Average Volume (20 Days) | 717,250 |
Short Selling Information
The latest short interest is 816,644, so 18.02% of the outstanding shares have been sold short.
| Short Interest | 816,644 |
| Short Previous Month | 363,268 |
| Short % of Shares Out | 18.02% |
| Short % of Float | 18.47% |
| Short Ratio (days to cover) | 2.02 |
Income Statement
In the last 12 months, BIAF had revenue of $5.66 million and -$15.88 million in losses. Loss per share was -$5.86.
| Revenue | 5.66M |
| Gross Profit | 1.87M |
| Operating Income | -11.56M |
| Pretax Income | -15.84M |
| Net Income | -15.88M |
| EBITDA | -11.10M |
| EBIT | -11.56M |
| Loss Per Share | -$5.86 |
Balance Sheet
The company has $3.10 million in cash and $1.38 million in debt, with a net cash position of $1.72 million or $0.38 per share.
| Cash & Cash Equivalents | 3.10M |
| Total Debt | 1.38M |
| Net Cash | 1.72M |
| Net Cash Per Share | $0.38 |
| Equity (Book Value) | 3.66M |
| Book Value Per Share | 0.81 |
| Working Capital | 1.16M |
Cash Flow
In the last 12 months, operating cash flow was -$10.91 million and capital expenditures -$15,445, giving a free cash flow of -$10.93 million.
| Operating Cash Flow | -10.91M |
| Capital Expenditures | -15,445 |
| Depreciation & Amortization | 464,766 |
| Net Borrowing | -349,041 |
| Free Cash Flow | -10.93M |
| FCF Per Share | -$2.41 |
Margins
Gross margin is 33.08%, with operating and profit margins of -204.29% and -280.57%.
| Gross Margin | 33.08% |
| Operating Margin | -204.29% |
| Pretax Margin | -279.95% |
| Profit Margin | -280.57% |
| EBITDA Margin | -196.07% |
| EBIT Margin | -204.29% |
| FCF Margin | n/a |
Dividends & Yields
BIAF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -492.85% |
| Shareholder Yield | -492.85% |
| Earnings Yield | -457.17% |
| FCF Yield | -314.66% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 19, 2025. It was a reverse split with a ratio of 1:30.
| Last Split Date | Sep 19, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
BIAF has an Altman Z-Score of -15.52 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.52 |
| Piotroski F-Score | 3 |